MedTrace Logo

Functional Dyspepsia Hypnosis

NCT03884270 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2022-04-01

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the efficacy of a hypnotherapy treatment program for functional dyspepsia that can be self-administered using on-line audio recordings. This is a non-randomized study. All patients will receive 7 sessions of hypnotherapy treatment administered over a 12-week period.

The primary objective of the study is to determine the feasibility and acceptability of the self-administered hypnotherapy program. The secondary objective is to evaluate the effect of the treatment on participant reported symptom severity, quality of life, anxiety and depression.

Conditions

  • Functional Dyspepsia

Interventions

BEHAVIORAL

Hypnotherapy

7 sessions of self-administered gut-directed hypnotherapy for functional dyspepsia

Sponsors & Collaborators

  • Sarah Kinsinger

    lead OTHER

Principal Investigators

  • Sarah Kinsinger, PhD · Loyola University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-05-03
Primary Completion
2020-11-03
Completion
2020-11-03

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03884270 on ClinicalTrials.gov